American Journal of Men's Health, 13 (2)
2 Materials and methods 2.1 Experimental design The experiment was conducted at the experimental station of the Institute of Animal Nutrition, Friedrich-Loeffler-Institute (FLI), in Braunschweig, Germany in accordance with the German Animal Welfare Act and permitted by the Lower Saxony State Office for Consumer Protection and Food Safety (LAVES, Oldenburg, Germany) (AZ33.19-42502-04-16/2378)
Later research showed that GLP-1 drugs also help control the appetite and cause weight loss in people who do not have diabetes
Mechanism of Action Pancreas: Increases glucose-dependent insulin secretion, decreases glucagon Brain: Enhances satiety Stomach: Slows gastric emptying Main Indications Type 2 diabetes mellitus Obesity/weight management Cardiovascular risk reduction Common Drugs Exenatide Liraglutide Semaglutide Dulaglutide Tirzepatide (dual GIP/GLP-1 agonist) Key Benefits Significant weight loss Low hypoglycemia risk Cardiovascular protection Major Side Effects Nausea/vomiting (most common) Pancreatitis (rare) Thyroid C-cell tumors (boxed warning) Contraindications Multiple Endocrine Neoplasia type 2 (MEN2) Personal/family history of medullary thyroid carcinoma #Pharmaceuticals #GLP1 #Diabetes #Obesity #Healthcare #Biotech #ClinicalResearch #Endocrinology #MedicalAffairs GLP-1 Analogues: Mechanism, Indications, and Side Effects GLP-1 Analogues : Definition Synthetic versions of the natural hormone GLP-1 (glucagon-like peptide-1) that are resistant to DPP-4 breakdown, providing longer-lasting effects
Fatty fish like salmon, mackerel, and sardines provide protein alongside omega-3 fatty acids that independently support insulin sensitivity and metabolic health
The 503A route ensures consistency and verified potency
